2m 2m 2m 2m 2m 2m 2m
EDGEWISE THERAP (EWTX)
NASDAQ
$41.31+$0.04 (+0.11%)
Price as of Jul 14, 2026 4:23 AM EDT- $4.9BMarket Cap
- 196.27%1-Year Change
- BiotechnologyIndustry
EDGEWISE THERAP (EWTX)
$41.31+$0.04 (+0.11%)
EWTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $41.27 | ||
Change | -$4.14 (-9.12%) | ||
Open | $43.67 | ||
High | $44.55 | ||
Low | $41.18 | ||
Previous Close | $45.41 | ||
Volume | 1,037,527 | ||
30-Day Average Volume | 1,714,600 | ||
1-Week Change | 2.92% | ||
1-Month Change | 18.49% | ||
1-Year Change | 196.27% | ||
3-Year Change | 452.48% | ||
5-Year Change | 72.25% | ||
Fundamentals | |||
Shares Outstanding | 107.6M | ||
Total Assets | $518.5M | ||
Market Cap | $4.9B | ||
Enterprise Value | $4.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$49.0M | ||
Free Cash Flow | -$42.8M | ||
EBIT | -$49.0M | ||
EBITDA | -$48.5M | ||
Net Working Capital | $487.2M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -100 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -99 | ||
PEG | -34 | ||
Price/Free Cash Flow | -114 | ||
Price/Operating Cash Flow | -115 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue